1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Background: Diabetes mellitus (DM) is a multisystem metabolic disorder shown to have adverse effects on lung physiology, immune responses, and antimicrobial defenses. However, the impact of DM on the development of poor in-hospital outcomes in patients with Acute COPD exacerbation (AECOPD) is unclea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser: ATLURI, RAMTEJ, RAMIREZ, MARCELO, SHAKA, HAFEEZ, MURTHI, MUKUNTHAN, CORPUZ, CARLOS GABRIEL D., VELAGAPUDI, SUJITHA, VELAZQUEZ, GENARO
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Diabetes (New York, N.Y.)
container_volume 70
creator ATLURI, RAMTEJ
RAMIREZ, MARCELO
SHAKA, HAFEEZ
MURTHI, MUKUNTHAN
CORPUZ, CARLOS GABRIEL D.
VELAGAPUDI, SUJITHA
VELAZQUEZ, GENARO
description Background: Diabetes mellitus (DM) is a multisystem metabolic disorder shown to have adverse effects on lung physiology, immune responses, and antimicrobial defenses. However, the impact of DM on the development of poor in-hospital outcomes in patients with Acute COPD exacerbation (AECOPD) is unclear. We aimed to assess this very impact in our study. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2018. About 394,929 hospitalizations had AECOPD as a primary diagnosis and were stratified based on the presence of DM using ICD-10 codes. Multivariate regression analysis was used to adjust for confounders and analyze variables. The selection of covariates was done with a univariate screen and literature review. Results: Out of the 394,929 hospitalized patients with AECOPD, 123,425 patients had DM. In-hospital mortality in AECOPD patients with DM was lower than those without (0.78% vs. 1.17%, p
doi_str_mv 10.2337/db21-1012-P
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2337_db21_1012_P</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2337_db21_1012_P</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_2337_db21_1012_P3</originalsourceid><addsrcrecordid>eNqVj81KxEAQhAdRMLqefIG-S3QmA4Z4W9YVvbg5CO5tmMx22JFNWqZ7_Hl7E_QFpA4FxVd0l1KXRl9X1tY3u64ypdGmKtsjVZjGNqWt6u2xKvQcmrqpT9UZ85vW-nZSofIvfQf30XcoyPDE8EwCS2YK0Qvu4DPKHl4pMcImS6BhouIIy5AFYf3lA6bOS6QRqIfVPtEYA2w6lpSDxA-ENh8GGn36nq4wesaFOun9gfHiz8_V1cP6ZfVYhkTMCXv3nuIwFZzRbl7m5mVu_tW19n_0D-9tVYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>ATLURI, RAMTEJ ; RAMIREZ, MARCELO ; SHAKA, HAFEEZ ; MURTHI, MUKUNTHAN ; CORPUZ, CARLOS GABRIEL D. ; VELAGAPUDI, SUJITHA ; VELAZQUEZ, GENARO</creator><creatorcontrib>ATLURI, RAMTEJ ; RAMIREZ, MARCELO ; SHAKA, HAFEEZ ; MURTHI, MUKUNTHAN ; CORPUZ, CARLOS GABRIEL D. ; VELAGAPUDI, SUJITHA ; VELAZQUEZ, GENARO</creatorcontrib><description>Background: Diabetes mellitus (DM) is a multisystem metabolic disorder shown to have adverse effects on lung physiology, immune responses, and antimicrobial defenses. However, the impact of DM on the development of poor in-hospital outcomes in patients with Acute COPD exacerbation (AECOPD) is unclear. We aimed to assess this very impact in our study. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2018. About 394,929 hospitalizations had AECOPD as a primary diagnosis and were stratified based on the presence of DM using ICD-10 codes. Multivariate regression analysis was used to adjust for confounders and analyze variables. The selection of covariates was done with a univariate screen and literature review. Results: Out of the 394,929 hospitalized patients with AECOPD, 123,425 patients had DM. In-hospital mortality in AECOPD patients with DM was lower than those without (0.78% vs. 1.17%, p&lt;0.001). Mean length of stay (LOS) and patient costs (PC) were higher in those with DM (4.1 vs. 3.92 days and $9242 vs. $8710 respectively). When adjusted to patient demographics, comorbidities and hospital characteristics, AECOPD patients with DM had a lower risk of mortality (aOR=0.49, p&lt;0.001), myocardial infarction (MI) (aOR=0.58, p&lt;0.001), pulmonary embolism (PE) (aOR=0.71, p=0.011), and stroke (aOR=0.68, p=0.047), as well as a higher risk develop an AKI (aOR=1.07, p=0.024). COPD patients with DM had less LOS by 0.09 days (p=0.007) and PC by $236 (p=0.03) after adjusting for similar covariates. There was no statistical significance in the risk of developing respiratory failure (aOR=0.97, p=0.165) and sepsis (aOR=0.74, p=0.173). Conclusion: DM in AECOPD did not have worse outcomes in terms of in-hospital mortality, LOS, and PC. DM patients had lower risk of MI, PE, and stroke, however, had higher risk of AKI. Further investigation is needed to understand the exact correlation between the paradoxical nature of outcomes in AECOPD in those with DM.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db21-1012-P</identifier><language>eng</language><ispartof>Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>ATLURI, RAMTEJ</creatorcontrib><creatorcontrib>RAMIREZ, MARCELO</creatorcontrib><creatorcontrib>SHAKA, HAFEEZ</creatorcontrib><creatorcontrib>MURTHI, MUKUNTHAN</creatorcontrib><creatorcontrib>CORPUZ, CARLOS GABRIEL D.</creatorcontrib><creatorcontrib>VELAGAPUDI, SUJITHA</creatorcontrib><creatorcontrib>VELAZQUEZ, GENARO</creatorcontrib><title>1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><title>Diabetes (New York, N.Y.)</title><description>Background: Diabetes mellitus (DM) is a multisystem metabolic disorder shown to have adverse effects on lung physiology, immune responses, and antimicrobial defenses. However, the impact of DM on the development of poor in-hospital outcomes in patients with Acute COPD exacerbation (AECOPD) is unclear. We aimed to assess this very impact in our study. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2018. About 394,929 hospitalizations had AECOPD as a primary diagnosis and were stratified based on the presence of DM using ICD-10 codes. Multivariate regression analysis was used to adjust for confounders and analyze variables. The selection of covariates was done with a univariate screen and literature review. Results: Out of the 394,929 hospitalized patients with AECOPD, 123,425 patients had DM. In-hospital mortality in AECOPD patients with DM was lower than those without (0.78% vs. 1.17%, p&lt;0.001). Mean length of stay (LOS) and patient costs (PC) were higher in those with DM (4.1 vs. 3.92 days and $9242 vs. $8710 respectively). When adjusted to patient demographics, comorbidities and hospital characteristics, AECOPD patients with DM had a lower risk of mortality (aOR=0.49, p&lt;0.001), myocardial infarction (MI) (aOR=0.58, p&lt;0.001), pulmonary embolism (PE) (aOR=0.71, p=0.011), and stroke (aOR=0.68, p=0.047), as well as a higher risk develop an AKI (aOR=1.07, p=0.024). COPD patients with DM had less LOS by 0.09 days (p=0.007) and PC by $236 (p=0.03) after adjusting for similar covariates. There was no statistical significance in the risk of developing respiratory failure (aOR=0.97, p=0.165) and sepsis (aOR=0.74, p=0.173). Conclusion: DM in AECOPD did not have worse outcomes in terms of in-hospital mortality, LOS, and PC. DM patients had lower risk of MI, PE, and stroke, however, had higher risk of AKI. Further investigation is needed to understand the exact correlation between the paradoxical nature of outcomes in AECOPD in those with DM.</description><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqVj81KxEAQhAdRMLqefIG-S3QmA4Z4W9YVvbg5CO5tmMx22JFNWqZ7_Hl7E_QFpA4FxVd0l1KXRl9X1tY3u64ypdGmKtsjVZjGNqWt6u2xKvQcmrqpT9UZ85vW-nZSofIvfQf30XcoyPDE8EwCS2YK0Qvu4DPKHl4pMcImS6BhouIIy5AFYf3lA6bOS6QRqIfVPtEYA2w6lpSDxA-ENh8GGn36nq4wesaFOun9gfHiz8_V1cP6ZfVYhkTMCXv3nuIwFZzRbl7m5mVu_tW19n_0D-9tVYQ</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>ATLURI, RAMTEJ</creator><creator>RAMIREZ, MARCELO</creator><creator>SHAKA, HAFEEZ</creator><creator>MURTHI, MUKUNTHAN</creator><creator>CORPUZ, CARLOS GABRIEL D.</creator><creator>VELAGAPUDI, SUJITHA</creator><creator>VELAZQUEZ, GENARO</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210601</creationdate><title>1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><author>ATLURI, RAMTEJ ; RAMIREZ, MARCELO ; SHAKA, HAFEEZ ; MURTHI, MUKUNTHAN ; CORPUZ, CARLOS GABRIEL D. ; VELAGAPUDI, SUJITHA ; VELAZQUEZ, GENARO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_2337_db21_1012_P3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ATLURI, RAMTEJ</creatorcontrib><creatorcontrib>RAMIREZ, MARCELO</creatorcontrib><creatorcontrib>SHAKA, HAFEEZ</creatorcontrib><creatorcontrib>MURTHI, MUKUNTHAN</creatorcontrib><creatorcontrib>CORPUZ, CARLOS GABRIEL D.</creatorcontrib><creatorcontrib>VELAGAPUDI, SUJITHA</creatorcontrib><creatorcontrib>VELAZQUEZ, GENARO</creatorcontrib><collection>CrossRef</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ATLURI, RAMTEJ</au><au>RAMIREZ, MARCELO</au><au>SHAKA, HAFEEZ</au><au>MURTHI, MUKUNTHAN</au><au>CORPUZ, CARLOS GABRIEL D.</au><au>VELAGAPUDI, SUJITHA</au><au>VELAZQUEZ, GENARO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2021-06-01</date><risdate>2021</risdate><volume>70</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Background: Diabetes mellitus (DM) is a multisystem metabolic disorder shown to have adverse effects on lung physiology, immune responses, and antimicrobial defenses. However, the impact of DM on the development of poor in-hospital outcomes in patients with Acute COPD exacerbation (AECOPD) is unclear. We aimed to assess this very impact in our study. Methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample from 2018. About 394,929 hospitalizations had AECOPD as a primary diagnosis and were stratified based on the presence of DM using ICD-10 codes. Multivariate regression analysis was used to adjust for confounders and analyze variables. The selection of covariates was done with a univariate screen and literature review. Results: Out of the 394,929 hospitalized patients with AECOPD, 123,425 patients had DM. In-hospital mortality in AECOPD patients with DM was lower than those without (0.78% vs. 1.17%, p&lt;0.001). Mean length of stay (LOS) and patient costs (PC) were higher in those with DM (4.1 vs. 3.92 days and $9242 vs. $8710 respectively). When adjusted to patient demographics, comorbidities and hospital characteristics, AECOPD patients with DM had a lower risk of mortality (aOR=0.49, p&lt;0.001), myocardial infarction (MI) (aOR=0.58, p&lt;0.001), pulmonary embolism (PE) (aOR=0.71, p=0.011), and stroke (aOR=0.68, p=0.047), as well as a higher risk develop an AKI (aOR=1.07, p=0.024). COPD patients with DM had less LOS by 0.09 days (p=0.007) and PC by $236 (p=0.03) after adjusting for similar covariates. There was no statistical significance in the risk of developing respiratory failure (aOR=0.97, p=0.165) and sepsis (aOR=0.74, p=0.173). Conclusion: DM in AECOPD did not have worse outcomes in terms of in-hospital mortality, LOS, and PC. DM patients had lower risk of MI, PE, and stroke, however, had higher risk of AKI. Further investigation is needed to understand the exact correlation between the paradoxical nature of outcomes in AECOPD in those with DM.</abstract><doi>10.2337/db21-1012-P</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)
issn 0012-1797
1939-327X
language eng
recordid cdi_crossref_primary_10_2337_db21_1012_P
source EZB-FREE-00999 freely available EZB journals; PubMed Central
title 1012-P: Diabetes Is Not Associated with Worse Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T08%3A47%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1012-P:%20Diabetes%20Is%20Not%20Associated%20with%20Worse%20Outcomes%20in%20Acute%20Exacerbation%20of%20Chronic%20Obstructive%20Pulmonary%20Disease&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=ATLURI,%20RAMTEJ&rft.date=2021-06-01&rft.volume=70&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db21-1012-P&rft_dat=%3Ccrossref%3E10_2337_db21_1012_P%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true